New Key Statistics Module, Z-Score and F-Score
NAS:SRPT Key Ratios
| Market Cap $ M | 10,935.09 |
| Enterprise Value $ M | 10,779.54 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 33.37 |
| Price/Book | 12.71 |
| Price/Sales | 8.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,243.00 |
| EPS (TTM) $ | -5.83 |
| Beneish M-Score | -1.47 |
| 10-y EBITDA Growth Rate % | -7.80 |
| 5-y EBITDA Growth Rate % | 3.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -21.64 |
| EV-to-EBITDA | -23.76 |
| PEG | -- |
| Shares Outstanding M | 93.86 |
| Net Margin (%) | -43.11 |
| Operating Margin % | -21.54 |
| Pre-tax Margin (%) | -41.83 |
| Quick Ratio | 3.45 |
| Current Ratio | 3.95 |
| ROA % (ttm) | -17.08 |
| ROE % (ttm) | -77.39 |
| ROIC % (ttm) | -27.74 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 5.00 |
| Positive ROA | N |
| Positive CFROA | N |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
SRPT Number of Guru Trades
SRPT Volume of Guru Trades
Gurus Latest Trades with NAS:SRPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SRPT is held by these investors
Total 3
Sarepta Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SRPT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers